Zentalis Pharmaceuticals, Inc. (ZNTL)
1.40
-0.02
(-1.41%)
USD |
NASDAQ |
Dec 19, 16:00
1.405
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals EPS Diluted (Quarterly): -0.37 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| Glaukos Corp. | -0.2828 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| Xtant Medical Holdings, Inc. | 0.0087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.69M |
| Total Expenses (Quarterly) | 26.69M |
| Enterprise Value | -139.09M |
| Earnings Yield | -148.8% |
| Normalized Earnings Yield | -139.94 |